Implementation, Effectiveness and Impact of a Value Based Intervention for Patients with Breast or Lung Cancer

NACompletedINTERVENTIONAL
Enrollment

1,007

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 31, 2020

Study Completion Date

March 30, 2023

Conditions
Breast CancerLung Cancer
Interventions
OTHER

VOICE intervention

"The intervention consists of four stages:~* S1, Value identification and description of current care processes: Needs are detected from two perspectives: feedback from patients and mapping of healthcare processes. ICHOM questionnaires are reviewed. Patient surveys and clinical forms are developed. The methodology for cost analysis is set up.~* S2, Intervention implementation: Patients are recruited according to the eligibility criteria. Their care follows the current healthcare pathway and information is collected at different time points.~* S3, Assessment of outcomes and continued benchmarking: Data and costs are analysed at both local level and Community level (benchmarking). Interviews and focus groups are held (optional). Root cause analysis is performed.~* S4, Best practice sharing: Identifying what lessons could be learned from the best-performing sites, according to the results of the VOICE community benchmarking and following qualitative techniques."

Trial Locations (8)

20014

Donostia University Hospital, San Sebastián

21005

Hospital Juan Ramón Jiménez, Huelva

28041

12 Octubre University Hospital, Madrid

47014

Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola

48903

Cruces University Hospital, Barakaldo

B-9300

Olv Aalst, Aalst

49 055

Institut de Cancerologie de l'Ouest, Angers

4200-072

Instituto Português de Oncologia do Porto, Porto

All Listed Sponsors
collaborator

Hospital de Cruces

OTHER

collaborator

Hospital Donostia

OTHER

collaborator

Hospital Universitario 12 de Octubre

OTHER

collaborator

Complejo Hospitalario de Especialidades Juan Ramón Jimenez

OTHER

collaborator

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

OTHER

collaborator

Instituto Portugues de Oncologia, Francisco Gentil, Porto

OTHER

collaborator

Onze Lieve Vrouwziekenhuis Aalst

OTHER

collaborator

UNICANCER

OTHER

lead

Biosistemak Institute for Health Systems Research

OTHER

NCT04960735 - Implementation, Effectiveness and Impact of a Value Based Intervention for Patients with Breast or Lung Cancer | Biotech Hunter | Biotech Hunter